Answers are grounded in this paper and cite their sources.
, epidemiological, and other study designs, including extensions for nanomaterials and micro- and nanoplastics. SciRAP applies harmonized criteria to assess study reliability and relevance, enabling consistent evaluation across diverse data streams. We highlight applications of SciRAP in regulatory contexts, Adverse Outcome Pathway (AOP) development, and systematic evidence synthesis, as well as its role in supporting reporting practices in academic research. Recent developments, including transition to Excel-based tools and emerging AI-assisted approaches, further enhance usability and scalability of the tools. By facilitating the integration of non-standard (eco)toxicity and human data, SciRAP strengthens the scientific basis of chemical risk assessment and supports the translation of academic research into policy-relevant evidence.
No takes yet. Share an insight, caveat, or question.
Hlisníková et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: